Advances in the Diagnosis of GERD Using the Esophageal pH Monitoring, Gastro-Esophageal Impedance-pH Monitoring, And Pitfalls

Authors

  • Mojgan Foroutan Department of Gastroenterology, Gastrointestinal and liver Diseases Research Center (RCGLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Homayoun Zojaji Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Mohammad Javad Ehsani Department of Gastroenterology and Hepatology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Mohammad Darvishi Infectious Diseases and Tropical Medicine Research Center (IDTMRC), Department of Aerospace and Subaquatic Medicine, AJA University of Medical Sciences, Tehran, Iran

DOI:

https://doi.org/10.3889/oamjms.2018.410

Keywords:

Impedance-pH monitoring, Gastro-esophageal, Reflux

Abstract

PH monitoring is not capable of detecting all types of reflux, especially when the amount of acid is very low or not at all in the refluxate. Multichannel intraluminal impedance-pH monitoring (MII-pH) is used as a new method to assess bolus transport. The types of reflexes including acid, weak acid and weak alkaline MII-pH is capable of distinguishing more reflux episodes based upon use of physical and chemical parameters of the refluxate, leads to a diagnosis of normal acid reflux from abnormal nonacidic reflux. 24-h oesophagal pH monitoring can be effectively used to assess the potential relationship between symptoms and refluxes. MII-pH is capable of distinguishing more reflux episodes based upon use of physical and chemical parameters of the refluxate, leads to a diagnosis of normal acid reflux from abnormal nonacidic reflux. It can be used to confirm gastro-oesophagal reflux episodes, where has a sensitivity and specificity for diagnosing GERD in comparison with endoscopy or pH-metry.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Ranaldo N, Losurdo G, Iannone A, et al. Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease. Cell Death & Disease. 2017; 8(9):e3040. https://doi.org/10.1038/cddis.2017.436 PMid:28880273 PMCid:PMC5636981

Frazzoni M, de Bortoli N, Frazzoni L, Tolone S, Savarino V, Savarino E. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives. Dig Dis Sci. 2017; 62(8):1881-1889. https://doi.org/10.1007/s10620-017-4625-8 PMid:28550489

Kahrilas P, Shaheen N, Vaezi M. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology. 2008; 135:1392–1413. https://doi.org/10.1053/j.gastro.2008.08.044 PMid:18801365

Katz P, Gerson L, Vela M. Guidelines for the diagnosis and management of gastroesophageal reflux disease.Am J Gastroenterol. 2013; 108:308–328. https://doi.org/10.1038/ajg.2012.444 PMid:23419381

Pohl D, Tutuian R. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements. Best Pract Res Clin Gastroenterol. 2009; 23(3):299-311. https://doi.org/10.1016/j.bpg.2009.04.003 PMid:19505660

Smout AJ. The patient with GORD and chronically recurrent problems. Best Pract Res Clin Gastroenterol. 2007; 21:365–78. https://doi.org/10.1016/j.bpg.2007.01.007 PMid:17544105

Bredenoord AJ, Weusten BL, Curvers WL, et al. Determinants of perception of heartburn and regurgitation. Gut. 2006; 55:313–8. https://doi.org/10.1136/gut.2005.074690 PMid:16120760 PMCid:PMC1856084

Vela MF, Camacho-Lobato L, Srinivasan R, et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: Effect of omeprazole. Gastroenterology. 2001; 120:1599–606. https://doi.org/10.1053/gast.2001.24840 PMid:11375942

Lind T, Havelund T, Carlsson R, Anker-Hansen O, Glise H, Hernqvist Het al.Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol. 1997;32: 974–979. https://doi.org/10.3109/00365529709011212 PMid:9361168

Galmiche JP, Clouse RE, Balint A, et al. Functional esophageal disorders. Gastroenterology. 2006; 130:1459–1465. https://doi.org/10.1053/j.gastro.2005.08.060 PMid:16678559

Savarino E, Zentilin P, Savarino V. NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol. 2013; 10:371–380. https://doi.org/10.1038/nrgastro.2013.50 PMid:23528345

Chu C, Du Q, Li C, et al. Ambulatory 24-hour multichannel intraluminal impedance-pH monitoring and high resolution endoscopy distinguish patients with non-erosive reflux disease from those with functional heartburn. Green J, ed. PLoS ONE. 2017; 12(4):e0175263.

Johnston BT, Lewis SA, Collins JS, McFarland RJ, Love AH. Acid perception in gastro-oesophageal reflux disease is dependent on psychosocial factors. Scandinavian journal of gastroenterology. 1995; 30(1):1–5. https://doi.org/10.3109/00365529509093228 PMid:7701244

Sifrim D, Fornari F. Esophageal impedance-pH monitoring. Dig Liver Dis. 2008; 40(3):161-6. https://doi.org/10.1016/j.dld.2007.10.023 PMid:18082474

Charbel S, Khandwala F, Vaezi MF. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol. 2005; 100(2):283–9. https://doi.org/10.1111/j.1572-0241.2005.41210.x PMid:15667483

Hong SK, Vaezi MF. Gastroesophageal reflux monitoring: pH (catheter and capsule) and impedance. Gastrointest Endosc Clin N Am. 2009; 19(1):1-22. https://doi.org/10.1016/j.giec.2008.12.009 PMid:19232277

Piper DW, Fenton BH. pH stability and activity curves of pepsin with special reference to their clinical importance. Gut. 1965; 6:506–8. https://doi.org/10.1136/gut.6.5.506

Roberts NB. Review article: human pepsins—their multiplicity, function and role in reflux disease. Aliment Pharmacol Ther. 2006; 24:2–9. https://doi.org/10.1111/j.1365-2036.2006.03038.x PMid:16939427

Pearson JP, Parikh S. Review article: nature and properties of gastro-oesophageal and extra-oesophageal refluxate. Aliment Pharmacol Ther. 2011; 33:2–7.

Orlando RC. Review article: oesophageal tissue damage and protection.Aliment Pharmacol Ther. 2011; 33:8–12.

Johnsson F, Joelsson B, Isberg PE. Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut. 1987; 28:1145–50. https://doi.org/10.1136/gut.28.9.1145 PMid:3315881 PMCid:PMC1433234

Kahrilas PJ, Quigley EMM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology. 1996; 110:1982–1996. https://doi.org/10.1053/gast.1996.1101982

Vitale GC, Sadek S, Tulley FM, et al. Computerized 24-hour esophageal pH monitoring: a new ambulatory technique using radiotelemetry. J Lab Clin Med. 1985; 105:686–93. PMid:3998621

Weusten BL, Roelofs JM, Akkermans LM, et al. Objective determination of pH thresholds in the analysis of 24 h ambulatory oesophageal pH monitoring. Eur J Clin Invest. 1996; 26:151–8. https://doi.org/10.1046/j.1365-2362.1996.104249.x PMid:8904525

Taghavi SA, Ghasedi M, Saberi-Firoozi M, et al. Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole. Gut. 2005; 54(8):1067-1071. https://doi.org/10.1136/gut.2004.054981 PMid:15845561 PMCid:PMC1774904

Breumelhof R, Smout AJPM. The symptom sensitivity index: A valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol. 1991; 86:160–4. PMid:1992627

Orr WC. The physiology and philosophy of cause and effect. Gastroenterology. 1994; 107:1897–901. https://doi.org/10.1016/0016-5085(94)90841-9

Bredenoord AJ, Weusten BL, Smout AJ. Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut. 2005; 54:1810–7. https://doi.org/10.1136/gut.2005.072629 PMid:16284291 PMCid:PMC1774780

Numans ME, Lau J, de Wit NJ, et al.(a) Bonis short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med. 2004; 140:518–27. https://doi.org/10.7326/0003-4819-140-7-200404060-00011 PMid:15068979

Sharma N, Agrawal A, Freeman J, Vela M, Castell DO. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Clin Gastroenterol Hepatol. 2008; 6:521–524. https://doi.org/10.1016/j.cgh.2008.01.006 PMid:18356117

Zerbib F, Roman S, Ropert A, et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol. 2006; 101:1956–1963. https://doi.org/10.1111/j.1572-0241.2006.00711.x PMid:16848801

Savarino E, Marabotto E, Zentilin P, et al. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis. 2011; 43:542–547. https://doi.org/10.1016/j.dld.2011.01.016 PMid:21376679

Vaezi MF. Use of Symptom Indices in the Management of GERD. Gastroenterology & Hepatology. 2012; 8(3):185-187.

Numans ME, Bonis PA, Lau J. (b), Limitations of gold standards for diagnosing gastroesophageal reflux disease. Ann Intern Med. 2004; 141:648–9. https://doi.org/10.7326/0003-4819-141-8-200410190-00020

Frazzoni M, Savarino E, Manno M, et al. Reflux patterns in patients with short segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy. Aliment Pharmacol Ther. 2009; 30:508–515. https://doi.org/10.1111/j.1365-2036.2009.04063.x PMid:19519732

Silny J. Intraluminal multiple electric impedance procedure for measurement of gastrointestinal motility. Neurogastroenterol Motil. 1991; 3:151–162. https://doi.org/10.1111/j.1365-2982.1991.tb00061.x

Mousa HM, Rosen R, Woodley FW, et al. Esophageal Impedance Monitoring for Gastroesophageal Reflux. Journal of pediatric gastroenterology and nutrition. 2011; 52(2):129-139. https://doi.org/10.1097/MPG.0b013e3181ffde67 PMid:21240010 PMCid:PMC3926211

Tutuian R, Castell DO. complete gastroâ€oesophageal reflux monitoring–combined pH and impedance. Alimentary pharmacology & therapeutics. 2006; 24:27-37. https://doi.org/10.1111/j.1365-2036.2006.03039.x PMid:16939430

Shin MS. Esophageal pH and Combined Impedance-pH Monitoring in Children. Pediatric Gastroenterology, Hepatology & Nutrition. 2014; 17(1):13-22. https://doi.org/10.5223/pghn.2014.17.1.13 PMid:24749083 PMCid:PMC3990778

Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and defini- tions of acid, non-acid, and gas reflux. Gut . 2004; 531024–1031. https://doi.org/10.1136/gut.2003.033290

Blondeau K, Tack J. Pro: impedance testing is useful in the man- agement of GERD. Am J Gastroenterol . 2009; 104:2664–2666. https://doi.org/10.1038/ajg.2009.568 PMid:19888230

Sifrim D, Zerbib F. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut. 2012; 61:1340–1354. https://doi.org/10.1136/gutjnl-2011-301897 PMid:22684483

Savarino E, Zentilin P, Tutuian R, et al. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol. 2008; 103:2685–2693. https://doi.org/10.1111/j.1572-0241.2008.02119.x PMid:18775017

Swidnicka-Siergiejko A, Dabrowski A. Prolonged 2-Day Esophageal pH-Metry with Impedance Monitoring Improves Symptom-Reflux Association Analysis. Digestive Diseases and Sciences. 2013; 58(9):2556-2563. https://doi.org/10.1007/s10620-013-2672-3 PMid:23589144 PMCid:PMC3766517

Ravi K, Katzka DA. Esophageal Impedance Monitoring: Clinical Pearls and Pitfalls. Am J Gastroenterol. 2016; 111(9):1245-56. https://doi.org/10.1038/ajg.2016.256 PMid:27325223

Herbella FAM. Critical Analysis of Esophageal Multichannel Intraluminal Impedance Monitoring 20 Years Later. ISRN Gastroenterology. 2012; 2012:903240. https://doi.org/10.5402/2012/903240 PMid:23150831 PMCid:PMC3488400

Oelschlager BK, Quiroga E, Isch JA, Cuenca-Abente F. Gastroesophageal and pharyngeal reflux detection using impedance and 24-hour pH monitoring in asymptomatic subjects: defining the normal environment. Journal of Gastrointestinal Surgery. 2006; 10(1):54–62. https://doi.org/10.1016/j.gassur.2005.09.005 PMid:16368491

Kahrilas PJ, Sifrim D. High-resolution manometry and impedance-pH/manometry: valuable tools in clinical and investigational esophagology. Gastroenterology. 2008; 135(3):756–769. https://doi.org/10.1053/j.gastro.2008.05.048 PMid:18639550 PMCid:PMC2892006

Shay S, Tutuian R, Sifrim D, et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. American Journal of Gastroenterology. 2004; 99(6):1037–1043. https://doi.org/10.1111/j.1572-0241.2004.04172.x PMid:15180722

Wasko-Czopnik D, Blonski W, Paradowski L. Diagnostic difficulties during combined multichannel intraluminal impedance and pH monitoring in patients with esophagitis or Barrett's esophagus. Adv Med Sci. 2007; 52:196–8. PMid:18217418

Tutuian R, Castell DO. Rumination documented by using combined multichannel intraluminal impedance and manometry. Clin Gastroenterol Hepatol. 2004; 2:340–3. https://doi.org/10.1016/S1542-3565(04)00065-5

Kessing BF, Govaert F, Masclee AA, et al. Impedance measurements and high-resolution manometry help to better define rumination episodes. Scand J Gastroenterol. 2011; 46:1310–5. https://doi.org/10.3109/00365521.2011.605467 PMid:21815865

Francis DO, Goutte M, Slaughter JC, et al. Traditional reflux parameters and not impedance monitoring predict outcome after fundoplication in extraesophageal reflux. Laryngoscope. 2011; 121(9):1902–1919. https://doi.org/10.1002/lary.21897

Rosen R, Levine P, Lewis J, Mitchell P, Nurko S. Reflux events detected by pH-MII do not determine fundoplication outcome. Journal of Pediatric Gastroenterology and Nutrition. 2010; 50(3):251–255. https://doi.org/10.1097/MPG.0b013e3181b643db PMid:20118804 PMCid:PMC3275907

Kessing BF , Bredenoord AJ , Weijenborg PW et al. Esophageal acid exposure decreases intraluminal baseline impedance levels . Am J Gastroenterol. 2011; 106:2093–7. https://doi.org/10.1038/ajg.2011.276 PMid:21844921

Martinucci I, de Bortoli N, Savarino E, et al. Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil. 2014; 26:546–55. https://doi.org/10.1111/nmo.12299 PMid:24433456

Arnold BN, Dunst CM, Gill AB, Goers TA, Swanström LL. Postoperative impedance-pH testing is unreliable after Nissen fundoplication with or without giant hiatal hernia repair. Journal of Gastrointestinal Surgery. 2011; 15(9):1506–1512. https://doi.org/10.1007/s11605-011-1597-4 PMid:21717283

Bredenoord AJ, Draaisma WA, Weusten BLAM, Gooszen HG, Smout AJPM. Mechanisms of acid, weakly acidic and gas reflux after anti-reflux surgery. Gut. 2008; 57(2):161–166. https://doi.org/10.1136/gut.2007.133298 PMid:17895353

Published

2018-10-26

How to Cite

1.
Foroutan M, Zojaji H, Ehsani MJ, Darvishi M. Advances in the Diagnosis of GERD Using the Esophageal pH Monitoring, Gastro-Esophageal Impedance-pH Monitoring, And Pitfalls. Open Access Maced J Med Sci [Internet]. 2018 Oct. 26 [cited 2021 Sep. 25];6(10):1934-40. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2018.410

Issue

Section

F - Review Articles